ZHAN, DONGQING – Trademark Portfolio

Entity Type: 01

ZHAN, DONGQING holds 3 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 9 (Computers & Electronics) — 2 filings in this category. The portfolio also extends into Class 25 (Clothing) across 2 Nice Classification classes. Currently, 3 trademarks are registered. Notable registered marks include GUIZREN, REDROMAN, and SUWEISHI. The owner is based in SHENZHEN.

NO.3039,BAOAN NORTH ROAD,LUOHU DISTRICT

SHENZHEN 518000 , CN

3 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

SUWEISHI
SUWEISHI
Registered 2021
GUIZREN
GUIZREN
Registered 2020
REDROMAN
REDROMAN
Registered 2020

Trademark Classifications

ZHAN, DONGQING's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

9
Computers & Electronics (2 filings)

Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments

25
Clothing (1 filing)

Clothing, footwear, headgear

Frequently Asked Questions

How many trademarks does ZHAN, DONGQING have?

ZHAN, DONGQING has 3 U.S. trademarks filed with the USPTO. Of these, 3 registered.

What trademark classes does ZHAN, DONGQING file in?

ZHAN, DONGQING files trademarks across 2 Nice Classification classes. The most active classes are Class 9 (Computers & Electronics), Class 25 (Clothing). Class 9 covers scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments.

What are ZHAN, DONGQING's most well-known trademarks?

ZHAN, DONGQING's registered trademark portfolio includes well-known marks such as GUIZREN, REDROMAN, and SUWEISHI. These are among 3 currently registered trademarks in the portfolio.

What is ZHAN, DONGQING's trademark registration success rate?

ZHAN, DONGQING has a 100% trademark registration rate, with 3 out of 3 resolved applications resulting in successful registration. Currently, 0 applications are pending review.